The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIq-ai Ltd Regulatory News (IQAI)

Share Price Information for Iq-ai Ltd (IQAI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.55
Bid: 1.50
Ask: 1.60
Change: 0.00 (0.00%)
Spread: 0.10 (6.667%)
Open: 1.55
High: 1.55
Low: 1.55
Prev. Close: 1.55
IQAI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Start of Trading on the OTCQB Venture Market

1 Sep 2021 10:00

RNS Number : 3752K
IQ-AI Limited
01 September 2021
 

September 1, 2021

IQ-AI Limited

("IQ-AI" or the "Company")

 

IQ-AI shares to commence trading on the OTCQB Venture Market in the United States

 

IQ-AI Limited (LSE: IQAI) is pleased to announce that the Company's ordinary shares will today begin trading on the OTCQB Venture Market ("OTCQB") in the United States, under the ticker symbol "IQAIF".

 

The Company's objective in listing its shares on the OTCQB is to provide more efficient access to a new and materially larger pool of prospective US investors. The Directors believe that IQ-AI's OTCQB listing will enable the Company to engage with a significant network of US investors, data distributors and media partners, ensuring that US investors have access to the same level of information and disclosure that is available to investors in the United Kingdom.

 

The OTCQB trading facility is provided through OTC Markets Group Inc, located in New York. OTC Markets Group Inc. operates the world's largest electronic interdealer quotation system for US broker dealers and offers multiple media channels to increase the visibility of OTC-listed companies. Independent studies show that trading on the OTCQB by an international company offers a positive effect on the liquidity of its shares.

 

Trading on the OTCQB market will have no impact on the IQ-AI ordinary shares admitted to listing on the London Stock Exchange's Main Market under the symbol "IQAI", and no new ordinary shares have been admitted as part of the OTCQB listing. The Company will continue to rely on the announcements and disclosures it makes to the London Stock Exchange and has no Sarbanes-Oxley or SEC reporting requirements.

 

IQ-AI CEO, Trevor Brown, commented:

 

"The United States is home to some of the world's most influential medical technology investors. By joining OTCQB, we now have an effective platform from which to reach a significantly larger investor audience and we look forward to providing investors in both the UK and the United States with regular progress updates at this exciting and pivotal time for the Company."

 

Jonathan Dickson, VP of International Corporate Services at OTC Markets, said:

 

"Congratulations to IQ-AI Ltd on joining the OTCQB Venture Market. We are pleased to support innovative and entrepreneurial international companies seeking to strengthen transparency and to provide better access to disclosure and trading for investors in the United States. Cross-trading on OTCQB in the U.S will enable IQ-AI, which is listed on the London Stock Exchange's Main Market, to diversify its investor base and to expand its global engagement even further."

 

The Company would like to thank Nikolaos Galanopoulos of Galanopoulos & Company, the corporate securities law firm that acted as Sponsor for the Company's application to commence cross-trading on the OTCQB.

 

The Directors of the Company accept responsibility for the contents of this announcement.

 

IQ-AI Limited

Trevor Brown/Dr Qu Li/Vinod Kaushal

 

0207 469 0930

 

Peterhouse Capital Limited

Lucy Williams/Heena Karani

 

0207 220 9797

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDDZGGLRMMGMZG
Date   Source Headline
3rd Jul 20086:23 pmRNSTrading Statement
4th Jun 20085:35 pmRNSHolding(s) in Company
2nd Jun 20089:59 amRNSCEO Appointment
29th May 20083:30 pmRNSTrading Statement
8th May 20085:01 pmRNSAnnual Information Update
8th May 20084:27 pmRNSBlocklisting Interim Review
8th May 20084:26 pmRNSAnnual Report and Accounts
23rd Apr 200810:19 amRNSAGM Statement
14th Mar 20087:01 amRNSFinal Results
29th Feb 20087:01 amRNSNotice of Final Results
17th Jan 20081:39 pmRNSTrading Statement
13th Nov 20075:59 pmRNSHolding(s) in Company
23rd Oct 20077:02 amRNSTrading Update
27th Sep 200711:18 amRNSTotal Voting Rights
26th Sep 200711:00 amRNSBlocklisting Interim Review
6th Sep 20073:27 pmRNSDirectorate Change
27th Jul 20077:01 amRNSInterim Results
9th Jul 20077:00 amRNSNotice of Interim Results
6th Jul 200710:50 amRNSHolding(s) in Company
1st Jun 20078:00 amRNSHolding(s) in Company
8th May 20072:29 pmRNSDirector/PDMR Shareholding
25th Apr 200710:10 amRNSHolding(s) in Company
17th Apr 200710:44 amRNSAGM Statement & Board Changes
27th Mar 20072:40 pmRNSBlocklisting Interim Review
20th Mar 20079:01 amRNSHolding(s) in Company
16th Mar 20077:01 amRNSFinal Results
26th Feb 20077:00 amRNSNotice of Results
22nd Jan 20077:02 amRNSTrading Statement
19th Jan 20072:45 pmRNSHolding(s) in Company
15th Jan 20071:41 pmRNSHolding(s) in Company
13th Dec 200612:19 pmRNSTotal Voting Rights
29th Nov 20069:01 amRNSShareholder & Board Change
18th Oct 20062:16 pmRNSHolding(s) in Company
16th Oct 200611:49 amRNSHolding(s) in Company
26th Sep 200610:31 amRNSBlocklisting Interim Review
21st Sep 200610:12 amRNSHolding(s) in Company
18th Sep 20067:01 amRNSAcquisition
10th Aug 200610:19 amRNSHolding(s) in Company
8th Aug 20067:01 amRNSTransaction in Own Shares
28th Jul 20067:01 amRNSInterim Results
18th Jul 20067:00 amRNSNotice of Interim Results
27th Jun 20064:52 pmRNSChange of Auditors
3rd May 20065:09 pmRNSDirectorate Change
28th Apr 20067:01 amRNSHolding(s) in Company
13th Apr 200610:15 amRNSAGM Statement
6th Apr 200610:26 amRNSDirector/PDMR Shareholding
24th Mar 20064:17 pmRNSAdditional Listing - Replace
23rd Mar 20063:28 pmRNSAdditional Listing
16th Mar 20063:18 pmRNSDirector/PDMR Shareholding
14th Mar 20063:43 pmRNSAnnual Information Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.